BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36151978)

  • 1. Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events.
    Jacobs SS; Withycombe JS; Castellino SM; Lin L; Mack JW; McFatrich M; Baker JN; Freyer DR; Maurer SH; Mowbray C; Hinds PS; Reeve BB
    Pediatr Blood Cancer; 2022 Dec; 69(12):e29986. PubMed ID: 36151978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of the caregiver Pediatric Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events measure.
    Reeve BB; McFatrich M; Lin L; Lucas NR; Mack JW; Jacobs SS; Withycombe JS; Baker JN; Freyer DR; Hinds PS
    Cancer; 2021 May; 127(9):1483-1494. PubMed ID: 33332590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of Concordance in Symptomatic Adverse Event Reporting by Children, Clinicians, and Caregivers: Implications for Cancer Clinical Trials.
    Freyer DR; Lin L; Mack JW; Maurer SH; McFatrich M; Baker JN; Jacobs SS; Lucas N; Withycombe JS; Tomlinson D; Villabroza KR; Waldron MK; Hinds PS; Reeve BB
    J Clin Oncol; 2022 May; 40(15):1623-1634. PubMed ID: 35294262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events.
    Reeve BB; McFatrich M; Mack JW; Maurer SH; Jacobs SS; Freyer DR; Withycombe JS; Baker JN; Castellino SM; Lin L; Lucas NR; Hinds PS
    J Natl Cancer Inst; 2020 Nov; 112(11):1143-1152. PubMed ID: 31999349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eliciting the child's voice in adverse event reporting in oncology trials: Cognitive interview findings from the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events initiative.
    Reeve BB; McFatrich M; Pinheiro LC; Weaver MS; Sung L; Withycombe JS; Baker JN; Mack JW; Waldron MK; Gibson D; Tomlinson D; Freyer DR; Mowbray C; Jacobs S; Palma D; Martens CE; Gold SH; Jackson KD; Hinds PS
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27650708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom Adverse Events and Quality of Life of Children With Advanced Cancer: Results From a Longitudinal Study Using the Pediatric Patient-Reported Outcomes-Common Terminology Criteria for Adverse Events.
    Grinde K; Raybin JL; Ward J; Smith C; Brown R; Montgomery KE
    J Pediatr Hematol Oncol Nurs; 2024; 41(1):5-15. PubMed ID: 37697734
    [No Abstract]   [Full Text] [Related]  

  • 7. Recommended scoring approach for the pediatric patient-reported outcomes version of the Common Terminology Criteria for Adverse Events.
    Hinds PS; Pinheiro LC; McFatrich M; Waldron M; Baker JN; Mowbray C; Maurer SH; Cheng Y; Reeve BB; Wang J
    Pediatr Blood Cancer; 2022 Jun; 69(6):e29452. PubMed ID: 34866311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subjective Toxicity Profiles of Children in Treatment for Cancer: A New Guide to Supportive Care?
    Hinds PS; Weaver MS; Withycombe JS; Baker JN; Jacobs SS; Mack JW; Maurer SH; McFatrich M; Pinheiro LC; Reeve BB; Wang J
    J Pain Symptom Manage; 2021 Jun; 61(6):1188-1195.e2. PubMed ID: 33096220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients, caregivers, and clinicians differ in performance status ratings: Implications for pediatric cancer clinical trials.
    Maurer SH; Hinds PS; Reeve BB; Mack JW; McFatrich M; Lin L; Withycombe JS; Jacobs SS; Baker JN; Castellino SM; Freyer DR
    Cancer; 2021 Oct; 127(19):3664-3670. PubMed ID: 34196962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding construct validity of established and new PROMIS Pediatric measures for children and adolescents receiving cancer treatment.
    Reeve BB; McFatrich M; Mack JW; Pinheiro LC; Jacobs SS; Baker JN; Withycombe JS; Lin L; Mann CM; Villabroza KR; Hinds PS
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28160. PubMed ID: 31904157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive Interview-Based Validation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Adolescents with Cancer.
    Reeve BB; McFatrich M; Pinheiro LC; Freyer DR; Basch EM; Baker JN; Withycombe JS; Sung L; Mack JW; Waldron MK; Mowbray C; Palma D; Hinds PS
    J Pain Symptom Manage; 2017 Apr; 53(4):759-766. PubMed ID: 28062347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating the patient voice with clinician reports to identify a hepatocellular carcinoma-specific subset of treatment-related symptomatic adverse events.
    Speck RM; Lenderking WR; Shaw JW
    J Patient Rep Outcomes; 2017; 2():35. PubMed ID: 30175317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PROMIS pediatric measures validated in a longitudinal study design in pediatric oncology.
    Hinds PS; Wang J; Cheng YI; Stern E; Waldron M; Gross H; DeWalt DA; Jacobs SS
    Pediatr Blood Cancer; 2019 May; 66(5):e27606. PubMed ID: 30663254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphoma.
    Wang XS; Giralt SA; Mendoza TR; Engstrom MC; Johnson BA; Peterson N; Broemeling LD; Cleeland CS
    J Clin Oncol; 2002 Mar; 20(5):1319-28. PubMed ID: 11870175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric lymphoma patients in Malawi present with poor health-related quality of life at diagnosis and improve throughout treatment and follow-up across all Pediatric PROMIS-25 domains.
    Ellis GK; Chapman H; Manda A; Salima A; Itimu S; Banda G; Seguin R; Manda G; Butia M; Huibers M; Ozuah N; Tilly A; Stover AM; Basch E; Gopal S; Reeve BB; Westmoreland KD
    Pediatr Blood Cancer; 2021 Oct; 68(10):e29257. PubMed ID: 34339099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping child and adolescent self-reported symptom data to clinician-reported adverse event grading to improve pediatric oncology care and research.
    McFatrich M; Brondon J; Lucas NR; Hinds PS; Maurer SH; Mack JW; Freyer DR; Jacobs SS; Baker JN; Mowbray C; Wang M; Castellino SM; Barz Leahy A; Reeve BB
    Cancer; 2020 Jan; 126(1):140-147. PubMed ID: 31553494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Longitudinal Study of PROMIS Pediatric Symptom Clusters in Children Undergoing Chemotherapy.
    Wang J; Jacobs S; Dewalt DA; Stern E; Gross H; Hinds PS
    J Pain Symptom Manage; 2018 Feb; 55(2):359-367. PubMed ID: 28865867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voices of children and adolescents on phase 1 or phase 2 cancer trials: A new trial endpoint?
    Hinds PS; Wang J; Stern ED; Macpherson CF; Wharton CM; Okorosobo R; Cheng YI; Gross HE; Meany HJ; Jacobs S
    Cancer; 2017 Oct; 123(19):3799-3806. PubMed ID: 28581685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translation, psychometric validation, and baseline results of the Patient-Reported Outcomes Measurement Information System (PROMIS) pediatric measures to assess health-related quality of life of patients with pediatric lymphoma in Malawi.
    Westmoreland K; Reeve BB; Amuquandoh A; van der Gronde T; Manthalu O; Correia H; Stanley C; Itimu S; Salima A; Chikasema M; Ward P; Mpasa A; Wachepa S; Mtete I; Butia M; Chasela M; Mtunda M; Wasswa P; Martin S; Kim NE; Kazembe P; Gopal S
    Pediatr Blood Cancer; 2018 Nov; 65(11):e27353. PubMed ID: 30015407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Adverse Events From the Patient Perspective in a Phase 3 Metastatic Castration-Resistant Prostate Cancer Clinical Trial.
    Dueck AC; Scher HI; Bennett AV; Mazza GL; Thanarajasingam G; Schwab G; Weitzman AL; Rogak LJ; Basch E
    JAMA Oncol; 2020 Feb; 6(2):e193332. PubMed ID: 31556911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.